DroneShield’s Cash Cushion and Record Backlog Do Little to Deter a Wall of Short Bets

Australian counter-drone specialist holds $223M cash with no debt and positive cash flow, but short interest at 12.19% and stock down 30% YTD despite $171M in committed orders for 2026.

The dissonance between DroneShield’s balance sheet and its stock price has rarely been wider. The Australian counter-drone specialist sits on roughly 223 million Australian dollars in cash with zero debt — a rarity among small-cap defence names — and has earned an exemption from Australia’s quarterly cash-flow reporting blackletter after posting four consecutive quarters of positive operating cash flow. Yet none of that has stopped bears from circling: short positions against the company now equal around 12.19% of outstanding shares, representing some 256 million Australian dollars in bets that the stock will fall further.

The timing of the short-sellers’ conviction is curious, given that DroneShield’s order book is bulging. Already in 2026, the company has secured at least 171 million Australian dollars in committed orders — a figure that covers nearly 79% of the total revenue it booked in the entire 2025 financial year. A recent US contract worth 24.9 million Australian dollars underscores the growing depth of its American footprint, with the US market now contributing roughly 29.7 million Australian dollars to global sales. NATO-aligned defence agencies and operators of critical infrastructure are also feeding the pipeline, gradually turning DroneShield from a supplier of individual equipment kits into a partner for multi-year procurement programmes.

None of that momentum is visible in the share price. After closing at 1.40 euros on Tuesday, the stock has slipped further to 1.39 euros in European trade on Wednesday, marking a year-to-date erosion of 30.07% and a 12-month decline of 28.56%. The gap to the 52-week high of 3.65 euros, set on 6 October 2025, has widened to nearly 62%. The relative-strength index sits at 36.9, signalling an approach to oversold territory, while the annualised 30-day volatility of 67.13% highlights the nervousness that has gripped the name. DroneShield now trades about 20% beneath its 50-day moving average of 1.75 euros and nearly 30% below the 200-day line of 1.97 euros.

The slide is all the more striking because the company has finally turned profitable. Net income for the latest reporting period came in at 3.52 million Australian dollars on aerospace & defence segment revenue of 216.8 million Australian dollars. Valuation multiples, however, remain stretched: the trailing price-to-earnings ratio is a towering 660.78, while the forward multiple — based on earnings estimates — still stands at 64.76. Part of the dilution pressure is clear in the share count, which swelled by 55.25% over the past year to 923.25 million shares, reflecting the cost of capital raises that helped fund growth.

On the governance front, DroneShield has strengthened its board with the appointment of Rear Admiral Lee Goddard as an independent non-executive director, effective 1 July 2026. Goddard brings more than three decades of national-security and defence experience. The company is also navigating a separate overhang: Australia’s corporate watchdog ASIC is conducting a review, a factor that the analysis platform Simply Wall St flags as adding complexity to the stock’s risk profile. Still, the broader sector backdrop remains supportive — at the NATO Summit Defence Industry Forum in Ankara early July, member states announced fresh initiatives on drone-defence capabilities, and the recent Series-E funding of German defence-AI firm Helsing at an $18 billion valuation underscores deep private-market appetite for the technology.

Analysts at Stock Analysis maintain a buy recommendation on DroneShield with a price target of 3.73 Australian dollars, implying upside of roughly 52.56% from the ASX closing price of 2.23 Australian dollars on 14 July. The operational trajectory is compelling, and the record order backlog suggests that momentum could accelerate. But with a net-debt-free balance sheet, a cash pile that dwarfs its modest liabilities, and an order book that already covers the bulk of last year’s revenue, the central question for investors is whether the market will eventually reward what the short sellers are betting against — or whether dilution, regulatory uncertainty, and the sheer weight of bearish positioning will keep the stock pinned near its lows.